18 Results for "

60686

" in MedChemExpress (MCE) Product Catalog:
Products (18)

18 Results for "60686" in MCE Product Catalog:

Cat. No.: HY-156649
CAS No.: 1417742-86-9
Purity:  99.72%
Synonyms: CR6086
Vorbipiprant (CR6086) is an orally active EP4 receptor antagonist with high selectivity for the human EP4 receptor (Ki: 16.6 nM). Vorbipiprant has immunomodulatory, anti-inflammatory, antitumor, and anti-angiogenic activities. Vorbipiprant can inhibit the expression of multiple pro-inflammatory cytokines and the activation of immune cells, and convert "cold" tumors unresponsive to immune checkpoint inhibitors into "hot" tumors. Vorbipiprant is used in the research of diseases such as rheumatoid arthritis and colon cancer .
Cat. No.: HY-15042
CAS No.: 578727-68-1
Purity:  99.76%
Target:  

Bradykinin Receptor

Research Areas:  

Metabolic Disease

MK 0686, a potent bradykinin B1 receptor antagonist, demonstrates autoinduction of metabolism in rhesus monkeys after oral administration. It undergoes significant biotransformation primarily via oxidation pathways, leading to the formation of metabolites like M11 and M13 in rhesus liver microsomes. This metabolic induction is mediated by CYP2C75, as evidenced by increased mRNA expression, protein levels, and catalytic activity of this enzyme in hepatocytes and liver microsomes from MK 0686-treated animals. The autoinduction phenomenon suggests that MK 0686 enhances its own metabolism by upregulating CYP2C75, potentially influencing its systemic exposure and pharmacokinetics over time .
Cat. No.: HY-15042A
CAS No.: 1159193-97-1
Target:  

Bradykinin Receptor

Research Areas:  

Metabolic Disease

(Rac)-MK 0686 is the racemate of MK 0686. MK 0686 is a bradykinin B1 receptor antagonist .
Cat. No.: HY-169229
CAS No.: 3097453-30-7
Target:  

5-HT Receptor

Research Areas:  

Cancer

GM-60186 is a 5-HT receptor 2B (HTR2B) inhibitor with an IC50 of 257 nM. GM-60186 significantly inhibits colorectal cancer proliferation and migration .
Cat. No.: HY-R01841
Target:  

MicroRNA

Research Areas:  

Cancer

hsa-miR-6068 mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.
Cat. No.: HY-R01861
Target:  

MicroRNA

Research Areas:  

Cancer

hsa-miR-6086 mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.
Cat. No.: HY-RI01841
Target:  

MicroRNA

Research Areas:  

Cancer

hsa-miR-6068 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.
Cat. No.: HY-RI01861
Target:  

MicroRNA

Research Areas:  

Cancer

hsa-miR-6086 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.
Cat. No.: HY-163651
CAS No.: 2502965-92-4
Synonyms: (R)-CR6086
Research Areas:  

Inflammation/Immunology

(R)-Vorbipiprant ((R)-CR6086) is an orally active antagonist for prostaglandin E2 receptor 4 (EP4) with Ki of 16.6 nM for human EP4. (R)-Vorbipiprant inhibits PGE2 (HY-101952)-induced cAMP production with an IC50 of 22 nM. (R)-Vorbipiprant exhibits immunomodulatory and anti-angiogenic activities, and ameliorates the collagen-induced arthritis in mice .
Cat. No.: HY-118095
CAS No.: 146667-75-6
Target:  

Drug Derivative

Research Areas:  

Others

A60586 is an active compound.
Cat. No.: HY-R01841A
Target:  

MicroRNA

Research Areas:  

Cancer

hsa-miR-6068 agomirs are chemically-modified double-strand miRNA mimics with modified mature miRNA strand: 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 3' end cholesterol group, and full-length nucleotide 2'-methoxy modification. They are designed to mimic endogenous miRNAs and recommended for miRNA functional studies. Compared with miRNA mimics, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.
Cat. No.: HY-R01861A
Target:  

MicroRNA

Research Areas:  

Cancer

hsa-miR-6086 agomirs are chemically-modified double-strand miRNA mimics with modified mature miRNA strand: 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 3' end cholesterol group, and full-length nucleotide 2'-methoxy modification. They are designed to mimic endogenous miRNAs and recommended for miRNA functional studies. Compared with miRNA mimics, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.
Cat. No.: HY-RI01841A
Target:  

MicroRNA

Research Areas:  

Cancer

hsa-miR-6068 antagomirs are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA antagomirs have 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 1 cholesterol group at the 3' end, and full-length nucleotide 2'-methoxy modification. The miRNA antagomirs strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning. Stability of miRNA antagomirs appears to be significantly higher than miRNA inhibitors, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.
Cat. No.: HY-RI01861A
Target:  

MicroRNA

Research Areas:  

Cancer

hsa-miR-6086 antagomirs are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA antagomirs have 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 1 cholesterol group at the 3' end, and full-length nucleotide 2'-methoxy modification. The miRNA antagomirs strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning. Stability of miRNA antagomirs appears to be significantly higher than miRNA inhibitors, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.
Cat. No.: HY-P86376
Synonyms: VEGFA; VEGF; Vascular endothelial growth factor A; VEGF-A; Vascular permeability factor; VPF

Host:  

Rabbit

Application:  

WB, IHC-P, ICC/IF, ELISA

Reactivity:  

Human, Mouse, Rat

Cat. No.: HY-P86374
Synonyms: Beclin-1 (Coiled-coil myosin-like BCL2-interacting protein) (Protein GT197)

Host:  

Rabbit

Application:  

WB, IHC-P, ICC/IF, IP, ELISA

Reactivity:  

Human, Mouse, Rat

Cat. No.: HY-P86394
Synonyms: CD9; MIC3; TSPAN29; GIG2; CD9 antigen; 5H9 antigen; Cell growth-inhibiting gene 2 protein; Leukocyte antigen MIC3; Motility-related protein; MRP-1; Tetraspanin-29; Tspan-29; p24; CD antigen CD9

Host:  

Rabbit

Application:  

WB, IHC-P, ICC/IF, IP, ELISA

Reactivity:  

Human, Mouse, Rat

Cat. No.: HY-P86993
Synonyms: 4933414E04Rik antibody; FLJ23743 antibody; NOL1/NOP2/Sun and PUA domain-containing protein 1 antibody; NOL1/NOP2/Sun domain family 6 antibody; NOL1/NOP2/Sun domain family member 6 antibody; NOP2 antibody; NOPD1 antibody; NSUN6 antibody; NSUN6_HUMAN antibody; nucleolar protein (NOL1/NOP2/sun) and PUA domains 1 antibody; 4933414E04Rik antibody; FLJ23743 antibody; NOL1/NOP2/Sun and PUA domain-containing protein 1 antibody; NOL1/NOP2/Sun domain family 6 antibody; NOL1/NOP2/Sun domain family member 6 antibody; NOP2 antibody; NOPD1 antibody; NSUN6 antibody; NSUN6_HUMAN antibody; nucleolar protein (NOL1/NOP2/sun) and PUA domains 1 antibody; Putative methyltransferase NSUN6 antibody; Sun domain family, member 6 antibody;

Host:  

Rabbit

Application:  

WB

Reactivity:  

Human, Mouse, Rat

  • 1